BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28276140)

  • 1. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
    Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
    BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
    Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ
    BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
    Jick SS; Hernandez RK
    BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
    Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB
    BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
    Parkin L; Sharples K; Hernandez RK; Jick SS
    BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    Bird ST; Delaney JA; Etminan M; Brophy JM; Hartzema AG
    J Thromb Haemost; 2013 Jun; 11(6):1059-68. PubMed ID: 23574590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism with drospirenone-containing oral contraceptives.
    Brown DA; Vartan CM
    Am J Health Syst Pharm; 2011 Jun; 68(11):1003-10. PubMed ID: 21593228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
    Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
    Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
    Schink T; Princk C; Braitmaier M; Haug U
    BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and venous thromboembolism: pill scares and public health.
    Reid RL
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1150-5. PubMed ID: 22082790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.